For citations:
Zanozina E.A., Bolotina L.V., Rasskazova E.A., Sipki V.N., Maksimov K.V., Zikiryakhodzhaev A.D. Neoadjuvant chemotherapy and pathological complete response in hormone-positive HER2-negative breast cancer: influence of progesterone receptor expression, tumor grade and Ki-67. MD-Onco. 2024;4(4):41-46. (In Russ.) https://doi.org/10.17650/2782-3202-2024-4-4-41-46